Vivelle-Dot

Product Category

US FDA-Approved Medicine

Formulation

ESTRADIOL: 0.0375 mg/day, 0.075 mg/day, 0.05 mg/day, 0.1 mg/day Film, extended release; transdermal Discontinued ESTRADIOL: 0.0375 mg/day, 0.075 mg/day, 0.05 mg/day, 0.1 mg/day, 0.025 mg/day Film, extended release; transdermal Prescription

Delivery Method

Film, Extended Release; Transdermal

Status

Prescription

ANDA #

020538

Approval Date

19960731

Therapeutic Equivalents

Manufacturers